BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814
29 results:

  • 1. Selective hif2a Inhibitors in the Management of Clear Cell Renal cancer and Von Hippel-Lindau-Disease-Associated Tumors.
    Suárez C; Vieito M; Valdivia A; González M; Carles J
    Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia.
    Toledo RA; Jimenez C; Armaiz-Pena G; Arenillas C; Capdevila J; Dahia PLM
    Endocr Rev; 2023 Mar; 44(2):312-322. PubMed ID: 36301191
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Shwachman Diamond syndrome: narrow genotypic spectrum and variable clinical features.
    Thompson AS; Giri N; Gianferante DM; Jones K; Savage SA; Alter BP; McReynolds LJ
    Pediatr Res; 2022 Dec; 92(6):1671-1680. PubMed ID: 35322185
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immunohistochemical expression of carbonic anhydrase 9, glucose transporter 1, and paired box 8 in von Hippel-Lindau disease-related lesions.
    Chatzopoulos K; Aubry MC; Gupta S
    Hum Pathol; 2022 May; 123():93-101. PubMed ID: 35196526
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A drug repositioning success: The repositioned therapeutic applications and mechanisms of action of thalidomide.
    Amare GG; Meharie BG; Belayneh YM
    J Oncol Pharm Pract; 2021 Apr; 27(3):673-678. PubMed ID: 33249990
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical manifestations of Pacak-Zhuang syndrome in a male pediatric patient.
    Abdallah A; Pappo A; Reiss U; Shulkin BL; Zhuang Z; Pacak K; Bahrami A
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28096. PubMed ID: 31876082
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of pancreatic cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MicroRNA-related transcription factor regulatory networks in human colorectal cancer.
    Hao S; Huo S; Du Z; Yang Q; Ren M; Liu S; Liu T; Zhang G
    Medicine (Baltimore); 2019 Apr; 98(15):e15158. PubMed ID: 30985693
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study.
    Huang L; Jansen L; Balavarca Y; Babaei M; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Primic-Žakelj M; Zadnik V; Besselink MG; Schrotz-King P; Brenner H
    BMC Med; 2018 Aug; 16(1):125. PubMed ID: 30126408
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote pancreatic cancer Metastasis.
    Wang X; Luo G; Zhang K; Cao J; Huang C; Jiang T; Liu B; Su L; Qiu Z
    Cancer Res; 2018 Aug; 78(16):4586-4598. PubMed ID: 29880482
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. HIF-3α Promotes Metastatic Phenotypes in pancreatic cancer by Transcriptional Regulation of the RhoC-ROCK1 Signaling Pathway.
    Zhou X; Guo X; Chen M; Xie C; Jiang J
    Mol Cancer Res; 2018 Jan; 16(1):124-134. PubMed ID: 28928287
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer.
    Zhang Q; Lou Y; Zhang J; Fu Q; Wei T; Sun X; Chen Q; Yang J; Bai X; Liang T
    Mol Cancer; 2017 Jul; 16(1):119. PubMed ID: 28705232
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.
    Därr R; Nambuba J; Del Rivero J; Janssen I; Merino M; Todorovic M; Balint B; Jochmanova I; Prchal JT; Lechan RM; Tischler AS; Popovic V; Miljic D; Adams KT; Prall FR; Ling A; Golomb MR; Ferguson M; Nilubol N; Chen CC; Chew E; Taïeb D; Stratakis CA; Fojo T; Yang C; Kebebew E; Zhuang Z; Pacak K
    Endocr Relat Cancer; 2016 Dec; 23(12):899-908. PubMed ID: 27679736
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for pancreatic cancer.
    Cerullo M; Gani F; Chen SY; Canner J; Pawlik TM
    J Gastrointest Surg; 2016 Sep; 20(9):1572-80. PubMed ID: 27255657
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PLGA/poloxamer nanoparticles loaded with epas1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
    Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
    Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer.
    Ngamruengphong S; Swanson KM; Shah ND; Wallace MB
    Gut; 2015 Jul; 64(7):1105-10. PubMed ID: 25575893
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality?
    Chernyak V; Flusberg M; Haramati LB; Rozenblit AM; Bellin E
    Radiology; 2015 Jan; 274(1):161-9. PubMed ID: 25117591
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy.
    de Haas S; Delmar P; Bansal AT; Moisse M; Miles DW; Leighl N; Escudier B; Van Cutsem E; Carmeliet P; Scherer SJ; Pallaud C; Lambrechts D
    Angiogenesis; 2014 Oct; 17(4):909-20. PubMed ID: 25012543
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A new twist in neuroendocrine tumor research: Pacak-Zhuang syndrome, HIF-2α as the major player in its pathogenesis and future therapeutic options.
    Jochmanova I; Lazurova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):175-80. PubMed ID: 24781045
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. cancer risk in patients with cholelithiasis and after cholecystectomy: a nationwide cohort study.
    Chen YK; Yeh JH; Lin CL; Peng CL; Sung FC; Hwang IM; Kao CH
    J Gastroenterol; 2014 May; 49(5):923-31. PubMed ID: 23807230
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.